已收盘
0.000
NaN.00%
Gainers Kazia Therapeutics (NASDAQ:KZIA) shares increased by 51.6% to $8.73 du...
2025-11-19 20:05
Viking Therapeutics (NASDAQ:VKTX) and other biotechs advancing drugs for a liver disease called metabolic dysfunction-associated steatohepatitis (MASH) gained on Thursday as the MASH space witnessed t...
2025-10-09 23:33
今日重点评级关注:Ascendiant Capital:维持Maison Solutions"买入"评级,目标价从4美元升至4.25美元;瑞穗:维持MBX Biosciences"跑赢大市"评级,目标价从38美元升至56美元
2025-09-25 09:52
Genfit (NASDAQ:GNFT) reported quarterly losses of $(0.23) per share. This is a 140.35 percent decrease over earnings of $0.57 per share from the same period last year. The company reported $40.443 million in sales this
2025-09-23 04:11
Companies Reporting Before The Bell Companies Reporting After The Bell • Genfit...
2025-09-22 16:32
HC Wainwright & Co. analyst Brandon Folkes assumes Genfit (NASDAQ:GNFT) with a Buy rating and announces Price Target of $9.
2025-08-19 19:13
Genfit SA ( ($GNFT) ) just unveiled an announcement. On April 29, 2025, GENFIT ...
2025-04-30 03:27
An update from Genfit SA ( ($GNFT) ) is now available. On February 21, 2025, GE...
2025-02-21 21:27
Genfit S.A (NASDAQ:GNFT) Friday said that it has signed put option agreements with 2025 OCEANEs holders and the convening of the general meeting of the 2025 OCEANEs holders for March 10, 2025. Genfit ...
2025-02-21 16:53
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1094906435582308353.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 瑞杰金融:维持Viking Therapeutics(VKTX)"强烈买入"评级,目标价从122美元升至125美元</p> <p>• Canaccord Genuity:维持HIVE Digital Technologie
2025-02-08 09:32